Introduction
Clinical criteria of kidney transplant rejection are unreliable and frequently inconclusive and it is often necessary to perform potentially hazardous procedures such as kidney biopsy and angiography. A simple test which could be carried out on the urine of a transplanted patient and would give a reliable indication of the condition of the transplant would be of great clinical value. Histological studies (Porter, 1967) have established that intrarenal fibrin deposition occurs during acute rejection episodes. Fibrin/fibrinogen degradation products (F.D.P.) have been shown by immunodiffusion and immunoelectrophoresis (Braun and Merrill, 1968; Antoine et al., 1969) in the urine of kidney transplant recipients, though the exact nature and source of these proteins remains uncertain. The use of the sensitive but laborious tanned red cell haemagglutination inhibition immunoassay (Clarkson et al., 1970) on the urine of kidney transplant recipients has shown that acute rejection episodes are accompanied by and occasionally preceded by increased F.D.P. excretion which subsides with recovery from the rejection episode. These findings have been confirmed using a much simpler latex slide agglutination technique (Hulme and Pitcher, 1973) . This paper reports the results of the serial estimation, by two different techniques, of the urinary F.D.P. excretion of a large number of kidney transplant patients in order to define its relation to transplant function and rejection and to assess its value in the clinical management of these patients.
Patients
Eighty-one cadaver kidney transplants were studied; 64 patients received a single transplant, 7 received a second, and 1 received a third transplant. Single early morning urine specimens were exaiined daily during the period in hospital and at each outpatient visit until stable renal function was achieved. Twentyeight patients with successful transplants were followed for periods of more than three months, including three for 12 months and one for 14 months. All 300-600 ,Lg/ml), has been reversed successfully. The recovery from a rejection episode is associated with a fall in F.D.P. excretion to undetectable levels. Irreversibly rejected kidneys, the result of either an acute rejection episode or a clinically silent rejection process, continue to excrete significant levels of F.D.P. (more than 20 ug/ml) for long periods. This enables these rejected kidneys to be distinguished from viable transplants with prolonged oliguric phases. The viable kidneys by the 20th day after transplantation, though oliguric, excrete only low levels (10 jug/ml or less) of F.D.P. in the urine. A good example of this was a patient whose F.D.P. excretion was less than 10 ,Lg/ml by the 20th day but whose transplant did not function until the 44th.
The long-term study of patients with functioning transplants has confirmed the findings of Clarkson et al. (1970) that episodic increases of F.D.P. excretion in the absence of clinical rejection episodes are not unommon. In 20% of these episodes, however, mild but permanent impairment of renal function has been observed. Whether increased immunosuppression at these times will prevent or delay renal damage remains to be determined.
The value of the urinary F.D.P. excretion in the first 10 days after transplantation, with the exception of transplants with immediate function, is limited by the high levels associated with the recovering acute tubular necrosis in the cadaver transplant. However, from the 15th day onwards it becomes a valuable measurement in the assessment of human kidney transplants. Most acute rejection episodes occur within three months of transplantation and during this period frequent testing is performed. Clearly large numbers of specimens have to be examined and such a laboratory burden can be accommodated conveniently only by an automated technique. Of the techniques used to measure urinary F.D.P. the immunonephelometric is the only one which lends itself to automation. This possibility is under investigation at the present time. 
Introduction
In the past few years the concept of a biological basis for homosexual behaviour has been reconsidered as a consequence of more precise investigative techniques. A previous study by Margolese (1970) showed that healthy adult males excreted androsterone and etiocholanolone in ratios that clearly discriminated between heterosexual and homosexual subjects. This was followed by a study by Lorraine (1970) who found low urinary testosterone in two homosexual males and raised urinary itestosterone in four homosexual females. The idea that changes in endocrine function might contribute to the genesis of homosexuality in humans was then given further impetus by Kolodny et al. (1971) who showed that plasma testosterone levels of a homosexual group were significantly lower than those of a control group. When investiga-ting several biochemical parameters Evans (1972) The present study was undertaken to investigate a larger number and greater variety of subjects -than previously, and to provide a more detailed psychological evaluation.
Subjects and Methods A total of 63 male subjects were s-tudied, which included two sets of identical twins. The heterosexual controls were obtained from college student populations. The homosexual subjects were obtained from four homosexual organizations (see acknowledgements).
One of us (M.S.M.) was responsible for the physical evaluation and endocrine studies. This consisted of a brief metabolic history, detemiination of blood pressure and pulse, and notations of sexual hair distribution, genitalia, and anthropometric measurements. A blood sample was drawn for determination of the SMA 12 blood chemisStry profile and free thyroxine. Each subject submitted a 24-hour specimen of urine which was analyzed for 17-ketosteroids, andros(terone, and etiocholanolone. In the case of six homosexuals the urines were -also analyzed for 17-ketogenic steroids. All blood and urine determinations were done by Bio-Science Laboratories of Van Nuys, California. The 17-ketosteroids were determined by a modification (Sabel et al., 1958) of the method of Drekter et al. (1952) . Androsterone and etiocholanolone were determined by the method of Brooks (1958) .
In the previous study a statistical analysis was done on the androsterone and eiocholanolone values by linear discriminant analysis. This provided a factor for androsterone (0 231) and for etiocholanolone (0190) and their differenoe (0-231A-0190E) gave a discri inant score. These factors are being used in the present study as a test of their ability to discriminate between two new populations.
Each subject was interviewed by one of us (O.J.) for one and a half to two hours, using a modified Kinsey sexual inventory. The Kinsey heterosexual-homosexual rating scale (Kinsey et al., 1948) was used for classifications, as follows: O exclusively heterosexual; 1 predominately heterosexual, only incidentally homosexual; 2 predominately heterosexual, but more than incidentally homosexual; 3 equally heterosexual and homosexual; 4 predominately homosexual, but more than incidentally heterosexual; 5 predominately homo-
